Anthelion Capital
Overview
Anthelion Capital is an investment and data science platform that provides flexible capital and data science solutions to environmentally sustainable companies . The firm invests in private credit and broadly syndicated bank loans in both primary and secondary markets . Anthelion Capital is primarily backed by large institutional investors including pension plans and sovereign wealth funds .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GreyOrange | Dec 2023 | Series D | Lead |
| Bevi | Aug 2022 | Series D | Lead |
| actnano | Oct 2024 | Series C | Lead |
| Quip | Aug 2021 | Series B | Lead |
| Aro Biotherapeutics | Nov 2023 | Series B | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Anthelion Capital based?
Anthelion Capital is headquartered in New York City, New York, United States.
When was Anthelion Capital founded?
Anthelion Capital was founded in 2015.
How many portfolio companies does Anthelion Capital have?
Anthelion Capital has 5 portfolio companies in Caplight's dataset.
What are some companies in Anthelion Capital's portfolio?
Portfolio companies visible on Caplight include GreyOrange, Bevi, actnano, Quip, Aro Biotherapeutics.
What was Anthelion Capital's most recent investment shown here?
Anthelion Capital's most recent investment in this portfolio sample was in actnano in 2024.
What sectors does Anthelion Capital focus on?
Anthelion Capital focuses on Healthcare & Life Sciences, Consumer & Commerce, Frontier & Industrial Tech, Frontier & Industrial Tech, Consumer & Commerce, Enterprise Software, Energy & Sustainability, Mobility, Transportation & Logistics, Healthcare & Life Sciences.
What company stages does Anthelion Capital focus on?
Anthelion Capital typically invests at the Mid stage.
What is Anthelion Capital's AUM?
Anthelion Capital's assets under management are estimated between $1.0B and $10.0B.